Pharmacy, Pharmaceutical Sciences, and Administration at University of Connecticut-Avery Point

The dramatic earnings jump from an estimated $49,000 in year one to $113,000 by year four tells you something important about pharmaceutical careers: they follow a licensing timeline. That first-year figure, drawn from national peer programs, likely captures graduates in residencies or pre-licensure positions. By year four, when most have completed their PharmD requirements and obtained licensure, earnings more than double—a pattern common in healthcare fields with mandatory credentialing periods.

With $27,000 in debt, UConn-Avery Point sits right at Connecticut's median for pharmacy programs but slightly above the national benchmark of $23,400. The debt-to-first-year-earnings ratio of 0.55 looks manageable on paper, though that estimate doesn't account for what licensed pharmacists actually earn from this specific campus. What matters more is that $27,000 against six-figure earnings potential creates a fundamentally different financial picture than many bachelor's programs. The debt sits in the 5th percentile nationally—meaning 95% of similar programs produce higher debt burdens.

The challenge is uncertainty. These estimates can't tell you whether UConn-Avery Point's particular program consistently produces licensed pharmacists earning $113,000, or whether graduates struggle more than average to reach that milestone. Given the campus's regional focus and Connecticut's competitive pharmacy market, you'd want to confirm the program's licensure pass rates and actual placement outcomes before committing.